Mesa Laboratories Inc 2025 SR
The report outlines Mesa Labs' sustainability progress under its 'Protecting the Vulnerable' framework, highlighting the inaugural disclosure of Scope 1 and 2 greenhouse gas emissions for fiscal years 2023 and 2024. Key environmental milestones include the Biopharmaceutical Development division's relocation to a LEED Platinum-certified facility and GKE's surplus solar energy generation. The company emphasizes workplace safety, reporting zero major incidents in 2024, and ethical supply chain management through mandatory supplier vetting. Community engagement is showcased through a long-standing partnership with REACH, Inc., which recycles 2.6 million glass tubes annually, and various local charitable initiatives.
Company: Mesa Laboratories Inc
Sector: Health Care
Country: United States
Year: 2025
Type: SR
Pages: 24
Mesa Laboratories Inc
Corporate Responsibility Brochure
The report outlines Mesa Labs' sustainability progress under its 'Protecting the Vulnerable' framework, highlighting the inaugural disclosure of Scope 1 and 2 greenhouse gas emissions for fiscal years 2023 and 2024. Key environmental milestones include the Biopharmaceutical Development division's relocation to a LEED Platinum-certified facility and GKE's surplus solar energy generation. The company emphasizes workplace safety, reporting zero major incidents in 2024, and ethical supply chain management through mandatory supplier vetting. Community engagement is showcased through a long-standing partnership with REACH, Inc., which recycles 2.6 million glass tubes annually, and various local charitable initiatives.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Employees